IL115199A - Composition comprising a polynucleic acid molecule in a liposome and method using said composition - Google Patents

Composition comprising a polynucleic acid molecule in a liposome and method using said composition

Info

Publication number
IL115199A
IL115199A IL11519995A IL11519995A IL115199A IL 115199 A IL115199 A IL 115199A IL 11519995 A IL11519995 A IL 11519995A IL 11519995 A IL11519995 A IL 11519995A IL 115199 A IL115199 A IL 115199A
Authority
IL
Israel
Prior art keywords
composition
liposome
polynucleic acid
acid molecule
vitro
Prior art date
Application number
IL11519995A
Other languages
English (en)
Other versions
IL115199A0 (en
Original Assignee
Opperbas Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opperbas Holding Bv filed Critical Opperbas Holding Bv
Priority to IL11519995A priority Critical patent/IL115199A/xx
Publication of IL115199A0 publication Critical patent/IL115199A0/xx
Priority to EP96929504A priority patent/EP0879062B1/fr
Priority to JP9512542A priority patent/JPH11514349A/ja
Priority to PCT/IL1996/000101 priority patent/WO1997010851A2/fr
Priority to DE69621953T priority patent/DE69621953T2/de
Priority to AT96929504T priority patent/ATE219380T1/de
Priority to US09/029,376 priority patent/US6207456B1/en
Priority to CA002231172A priority patent/CA2231172A1/fr
Priority to AU68884/96A priority patent/AU703271C/en
Publication of IL115199A publication Critical patent/IL115199A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL11519995A 1995-09-07 1995-09-07 Composition comprising a polynucleic acid molecule in a liposome and method using said composition IL115199A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IL11519995A IL115199A (en) 1995-09-07 1995-09-07 Composition comprising a polynucleic acid molecule in a liposome and method using said composition
EP96929504A EP0879062B1 (fr) 1995-09-07 1996-09-05 Vehicule pour delivrer des acides nucleiques dans les cellules
JP9512542A JPH11514349A (ja) 1995-09-07 1996-09-05 核酸デリバリー担体
PCT/IL1996/000101 WO1997010851A2 (fr) 1995-09-07 1996-09-05 Vehicule de transfert d'acide nucleique
DE69621953T DE69621953T2 (de) 1995-09-07 1996-09-05 Vehikel zum einbringen von nukleinsäuren in zellen
AT96929504T ATE219380T1 (de) 1995-09-07 1996-09-05 Vehikel zum einbringen von nukleinsäuren in zellen
US09/029,376 US6207456B1 (en) 1995-09-07 1996-09-05 Nucleic acid delivery vehicle
CA002231172A CA2231172A1 (fr) 1995-09-07 1996-09-05 Vehicule de transfert d'acide nucleique
AU68884/96A AU703271C (en) 1995-09-07 1996-09-05 Nucleic acid delivery vehicle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11519995A IL115199A (en) 1995-09-07 1995-09-07 Composition comprising a polynucleic acid molecule in a liposome and method using said composition

Publications (2)

Publication Number Publication Date
IL115199A0 IL115199A0 (en) 1995-12-31
IL115199A true IL115199A (en) 2005-05-17

Family

ID=11067956

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11519995A IL115199A (en) 1995-09-07 1995-09-07 Composition comprising a polynucleic acid molecule in a liposome and method using said composition

Country Status (8)

Country Link
US (1) US6207456B1 (fr)
EP (1) EP0879062B1 (fr)
JP (1) JPH11514349A (fr)
AT (1) ATE219380T1 (fr)
CA (1) CA2231172A1 (fr)
DE (1) DE69621953T2 (fr)
IL (1) IL115199A (fr)
WO (1) WO1997010851A2 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
DE19605548A1 (de) * 1996-02-15 1997-09-04 Boehringer Ingelheim Int Zusammensetzung für die Transfektion höherer eukaryotischer Zellen
FR2751222B1 (fr) 1996-07-16 1998-10-09 Capsulis Compositions contenant au moins un acide nucleique et leurs applications dans le domaine biomedical, en particulier en therapie genique
DE19740092A1 (de) * 1997-09-12 1999-03-18 Ulrich Dr Med Hengge Liposomen und Verfahren zur Transfektion von Zellen
WO1999042091A2 (fr) * 1998-02-19 1999-08-26 Massachusetts Institute Of Technology Compositions d'apport dans des cellules
US7276359B1 (en) * 1998-03-13 2007-10-02 Wyeth Polynucleotide composition, method of preparation, and use thereof
IL126681A0 (en) * 1998-10-21 1999-08-17 Opperbas Holding Bv Treatment of trauma-related conditions
EP1361862B1 (fr) * 2001-02-22 2007-04-18 Opperbas Holding B.V. Administration d'adn induite par des liposomes
ATE466871T1 (de) 2001-07-13 2010-05-15 Cms Peptides Patent Holding Co Biologisch aktive peptide
CN1210294C (zh) * 2001-07-13 2005-07-13 一泰医药研究（深圳）有限公司 序列号21的生物活性肽
JP2006501838A (ja) * 2002-10-09 2006-01-19 ファイザー・プロダクツ・インク 安定化された裸ｄｎａ組成物
JP2006520604A (ja) * 2003-03-19 2006-09-14 アイソジェニス・インコーポレイテッド ＣＤ８α鎖に基づき免疫原性が減少した遺伝子治療ベクター
TWI353252B (en) 2004-04-28 2011-12-01 Cms Peptides Patent Holding Company Ltd Biologically active peptide vapeehptllteaplnpk der
CN101068574B (zh) * 2004-07-20 2012-07-18 伊索格尼斯股份有限公司 与自身抗原有关的自身免疫和疾病的特异性抑制
KR101381337B1 (ko) 2005-07-26 2014-04-11 씨엠에스 펩티드 패턴트 홀딩 컴퍼니 리미티드 신규한 생물학적 활성 펩티드 및 그의 신규한 용도
US20070031512A1 (en) * 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
US20100272769A1 (en) * 2005-08-03 2010-10-28 Amcol International Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use
US20080184618A1 (en) * 2005-08-03 2008-08-07 Amcol International Virus-Interacting Layered Phyllosilicates and Methods of Use
WO2007051303A1 (fr) 2005-11-02 2007-05-10 Protiva Biotherapeutics, Inc. Molecules d'arnsi modifiees et utilisations de celles-ci
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
EP2058009A4 (fr) * 2006-08-31 2009-10-28 Astellas Pharma Inc Vésicule de lipide à ciblage inverse
EP2086507B1 (fr) * 2006-10-06 2018-11-07 BioNet Pharma GmbH Implant de noyau gélatineux spinal
EP2431043A1 (fr) * 2007-05-23 2012-03-21 Amcol International Corporation Phyllosilicates en couches interagissant avec le cholestérol pour supprimer l'absorption gastrointestinale de cholestérol
CA2710713C (fr) 2007-12-27 2017-09-19 Protiva Biotherapeutics, Inc. Silencage de l'expression de la polo-like kinase a l'aide d'un arn interferent
AU2009236219B8 (en) 2008-04-15 2015-06-25 Arbutus Biopharma Corporation Silencing of CSN5 gene expression using interfering RNA
WO2010033722A2 (fr) 2008-09-17 2010-03-25 Isogenis, Inc. Construction de vecteurs de délivrance de gènes basés sur un adénovirus complètement délété et ses utilisations
US20130164380A1 (en) 2010-06-17 2013-06-27 Actogenix Nv Compositions and methods for treating inflammatory conditions
US10849975B2 (en) 2011-02-03 2020-12-01 Thomas Jefferson University Multivalent vaccines for rabies virus and filoviruses
WO2013075132A1 (fr) 2011-11-17 2013-05-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions de commutateurs arn thérapeutiques et procédés d'utilisation
US9035039B2 (en) 2011-12-22 2015-05-19 Protiva Biotherapeutics, Inc. Compositions and methods for silencing SMAD4
BR112015006176B1 (pt) 2012-09-21 2023-04-18 Intensity Therapeutics, Inc Uso de um agente terapêutico e de um agente de intensificação de permeação intracelular
SG11201702662UA (en) 2014-10-02 2017-04-27 Protiva Biotherapeutics Inc Compositions and methods for silencing hepatitis b virus gene expression
WO2016164827A1 (fr) 2015-04-09 2016-10-13 Bikanta Corporation Systèmes et procédés d'imagerie utilisant des nanodiamants fluorescents
WO2016197132A1 (fr) 2015-06-04 2016-12-08 Protiva Biotherapeutics Inc. Traitement d'une infection à virus de l'hépatite b à de l'aide de crispr
WO2017019891A2 (fr) 2015-07-29 2017-02-02 Protiva Biotherapeutics, Inc. Compositions et méthodes de silençage de l'expression du gène du virus de l'hépatite b
US20170360815A1 (en) 2016-02-25 2017-12-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
CN109069520A (zh) 2016-02-25 2018-12-21 应用生物实验室公司 保护空气传播的病原体和刺激物的组合物和方法
EP4104854A3 (fr) 2016-04-04 2023-03-08 The United States of America as represented by the Secretary of the Department of Health and Human Services Vaccins multivalents pour le virus de la rage et les coronavirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283122A (en) 1984-04-19 1994-02-01 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
ATE157012T1 (de) * 1989-11-03 1997-09-15 Univ Vanderbilt Verfahren zur in vivo-verabreichung von funktionsfähigen fremden genen
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
US5928944A (en) 1994-02-04 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method of adenoviral-medicated cell transfection

Also Published As

Publication number Publication date
JPH11514349A (ja) 1999-12-07
CA2231172A1 (fr) 1997-03-27
IL115199A0 (en) 1995-12-31
EP0879062B1 (fr) 2002-06-19
ATE219380T1 (de) 2002-07-15
AU703271B2 (en) 1999-03-25
DE69621953D1 (de) 2002-07-25
DE69621953T2 (de) 2003-01-30
WO1997010851A3 (fr) 1997-06-05
US6207456B1 (en) 2001-03-27
AU6888496A (en) 1997-04-09
WO1997010851A2 (fr) 1997-03-27
EP0879062A2 (fr) 1998-11-25

Similar Documents

Publication Publication Date Title
IL115199A (en) Composition comprising a polynucleic acid molecule in a liposome and method using said composition
ID18631A (id) Proses pembuatan asam l-amino melalui fermentasi
AU4981101A (en) Subtilisin variants
MX9703063A (es) Compuestos de ester y acido boronico, su sintesis y usos.
SI1077692T1 (en) Amino acid stabilized gabapentin and pregabalin preparations and process for preparing the same
IL121046A0 (en) Semipermeable encapsulated membranes with improved acid and base stability process for their manufacture and their use
AU6568594A (en) Nucleic acid tranfer peptides and their use for injecting nucleic acids into eucaryotic cells
IL135823A0 (en) Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
IL132951A0 (en) Compounds preparation and use for transferring nucleic acids into cells
HUP9800049A3 (en) Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf
AR244544A1 (es) Composicion desodorante.
NZ292565A (en) Production of stabilised complement protein-3 convertase
AU4257789A (en) Electro-insertion of proteins into animal cell membranes
SE9501472D0 (sv) Truncated IGF-I
WO1997009420A3 (fr) Codage de sequences d'adn destine a une metalloproteinase humaine et ses variants
AU8505898A (en) Nucleic acid compositions and methods of introducing nucleic acids into cells
ES8900018A1 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
IL129139A0 (en) Vertebrate smoothened proteins
HUT75831A (en) Non-splicing variants of gp350/220
PL320084A1 (en) Nucleic acids of amino acid type
ES2189014T3 (es) Procedimiento para insomerizacion de alcoholes alilicos.
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
EP0317279A3 (fr) Peptides pour l'usage dans la purification du facteur-VIII
GB9615852D0 (en) Production of amino acids and enzymes used therefor
WO1996005286A3 (fr) Accelerateurs et inhibiteurs de la mort cellulaire

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees